ClinicalTrials.gg

Drug

Sevabertinib clinical trials

Also written BAY2927088.

studies test it
8
open now
3
in phase 3
1
first study started
2024

Keep track of what changes. Save the sevabertinib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Sevabertinib
3

Development codes

BAY2927088
4

Studies by the year they started

8 studies that test it; most in 2024 (5)

Studies that test sevabertinib, by start year
YearStudies
20245
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
1
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 8 · Other 0

Bayer (8)

Often tested with

Tested in the same studies.

Esomeprazole (1) · Dabigatran (1) · Rosuvastatin (1) · Midazolam (1) · Metformin (1)

Studies

Open first, then newest update. How each study uses sevabertinib is read from its arms, and is right about nine times in ten.

Testing it · 8

Given in every arm · 1 — sevabertinib is usual care beside what is tested

Codes

What other systems call sevabertinib · ClinicalTrials.gg INT002180

  • MeSH (NLM) C000731961sevabertinibOne source NLM
  • UNII (FDA) 2A7VPM5RWHSEVABERTINIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q137258574sevabertinibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C185187SevabertinibOne source FDA
  • DrugBank DB21667One source Wikidata

Also registered as sevabertinib hydrate (UNII R3MU6CA5SZ).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.